Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jay Kincannon

Concepts (103)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epidermolysis Bullosa
1
2025
3
0.970
Why?
Nephrotic Syndrome
1
2025
18
0.950
Why?
Lung Diseases, Interstitial
1
2025
24
0.940
Why?
Hair Diseases
2
2016
7
0.610
Why?
Lichen Sclerosus et Atrophicus
1
2012
7
0.410
Why?
Skin Diseases, Vesiculobullous
1
2012
8
0.410
Why?
Neck
1
2012
99
0.390
Why?
Dermatitis
2
2024
35
0.310
Why?
Dermatitis, Atopic
2
2024
34
0.280
Why?
Nevus, Epithelioid and Spindle Cell
1
2005
15
0.250
Why?
Heterozygote
1
2025
83
0.240
Why?
Lupus Erythematosus, Cutaneous
1
2024
2
0.220
Why?
Syphilis
1
2024
27
0.220
Why?
Medication Adherence
1
2024
129
0.210
Why?
Hyperoxaluria
1
2022
4
0.210
Why?
Hyperoxaluria, Primary
1
2022
3
0.210
Why?
Urolithiasis
1
2022
4
0.210
Why?
Skin Diseases, Genetic
1
2023
8
0.210
Why?
Dermatology
1
2024
52
0.210
Why?
Lupus Erythematosus, Systemic
1
2023
69
0.200
Why?
Eosinophilia
1
2023
35
0.200
Why?
Diagnosis, Differential
2
2016
1033
0.180
Why?
Kidney Failure, Chronic
1
2022
201
0.180
Why?
Dermatologic Surgical Procedures
1
2020
34
0.170
Why?
Skin Neoplasms
1
2005
491
0.170
Why?
Lasers, Solid-State
1
2020
32
0.170
Why?
Veins
1
2020
73
0.170
Why?
Humans
18
2025
50503
0.160
Why?
Mutation
1
2025
1280
0.160
Why?
Erythrasma
1
1998
1
0.150
Why?
Protein Synthesis Inhibitors
1
1998
17
0.150
Why?
Erythema
2
2023
36
0.150
Why?
Vascular Malformations
1
2020
102
0.150
Why?
Child, Preschool
6
2020
3942
0.150
Why?
Clarithromycin
1
1998
38
0.150
Why?
Skin
1
2020
388
0.140
Why?
Warts
2
2010
13
0.140
Why?
Patch Tests
1
1997
6
0.140
Why?
Dermatitis, Contact
1
1997
3
0.140
Why?
Antigens, Fungal
2
2010
19
0.140
Why?
Hair
1
2016
25
0.130
Why?
Immunotherapy
2
2010
235
0.120
Why?
Female
10
2022
27081
0.110
Why?
Anti-Bacterial Agents
1
1998
745
0.100
Why?
Hemorrhage
1
2012
197
0.090
Why?
Biopsy
1
2012
588
0.090
Why?
Candida
1
2010
59
0.090
Why?
Adolescent
5
2020
6443
0.090
Why?
Child
5
2024
6906
0.080
Why?
Neprilysin
1
2008
13
0.080
Why?
Hamartoma Syndrome, Multiple
1
2008
14
0.080
Why?
Antigens, CD34
1
2008
75
0.070
Why?
Proto-Oncogene Proteins c-bcl-2
1
2008
128
0.070
Why?
Immunohistochemistry
2
2008
957
0.070
Why?
Upper Extremity
1
2005
43
0.060
Why?
Biopsy, Needle
1
2005
178
0.060
Why?
Young Adult
3
2022
4102
0.060
Why?
Dermatologic Agents
1
2004
10
0.060
Why?
Skin Diseases
2
2003
112
0.060
Why?
Tacrolimus
1
2004
53
0.060
Why?
Antigens, Viral
1
2003
42
0.050
Why?
Infant
2
2023
3628
0.050
Why?
Oxalates
1
2022
11
0.050
Why?
Follow-Up Studies
2
2005
2242
0.050
Why?
Immunosuppressive Agents
1
2004
225
0.050
Why?
Rare Diseases
1
2023
43
0.050
Why?
Caregivers
1
2024
217
0.050
Why?
Risk Assessment
1
2005
1270
0.050
Why?
Photography
1
2020
30
0.040
Why?
Single-Blind Method
1
2020
114
0.040
Why?
Eyelashes
1
1999
3
0.040
Why?
Adult
3
2022
13577
0.040
Why?
Lymphedema
1
1999
46
0.040
Why?
Corynebacterium
1
1998
1
0.040
Why?
Treatment Outcome
3
2020
5283
0.040
Why?
Prospective Studies
2
2020
2378
0.040
Why?
Injections, Intralesional
2
2010
31
0.040
Why?
Conjunctival Neoplasms
1
1997
6
0.030
Why?
Sebaceous Glands
1
1997
13
0.030
Why?
Eye Abnormalities
1
1997
24
0.030
Why?
Choristoma
1
1997
24
0.030
Why?
Facial Neoplasms
1
1997
22
0.030
Why?
Nevus, Pigmented
1
1997
34
0.030
Why?
Ectodermal Dysplasia
1
1996
6
0.030
Why?
Tooth Abnormalities
1
1996
12
0.030
Why?
Infant, Newborn
1
2023
2749
0.030
Why?
Retrospective Studies
2
2020
6263
0.030
Why?
Male
5
2020
25907
0.020
Why?
Immunity, Cellular
1
2010
63
0.020
Why?
Brain
1
1997
1319
0.020
Why?
Hair Follicle
1
2008
18
0.020
Why?
Epidermal Cyst
1
2008
12
0.020
Why?
Syndrome
2
1999
240
0.020
Why?
Mumps
1
2003
13
0.010
Why?
Candidiasis
1
2003
111
0.010
Why?
Severity of Illness Index
1
2003
978
0.010
Why?
Lacrimal Apparatus Diseases
1
1997
6
0.010
Why?
Optic Disk
1
1997
21
0.010
Why?
Dental Caries
1
1996
8
0.010
Why?
Pedigree
1
1996
119
0.010
Why?
Alopecia
1
1996
29
0.010
Why?
Middle Aged
1
2010
12611
0.010
Why?
Magnetic Resonance Imaging
1
1997
1548
0.010
Why?
Kincannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description